01 1American Massage Therapy Association
02 1Bayer AG
03 8Covis Pharma
04 2Hanlim Pharmaceuticals Inc
05 7Viatris
01 1Nisoldipine 10Mg 24 Units Of Oral Use
02 2TABLET
03 16TABLET, EXTENDED RELEASE;ORAL
01 6DISCN
02 2Generic
03 10RX
04 1Blank
01 2NISOLDIN
02 8NISOLDIPINE
03 8SULAR
04 1Syor
01 1Italy
02 2South Korea
03 16USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8.5MG
Packaging :
Approval Date : 2023-04-10
Application Number : 216606
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Syor
Dosage Form : Nisoldipine 10Mg 24 Units Of Oral Use
Dosage Strength : 24 cpr riv 10 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1995-02-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 34MG
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 17MG
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SULAR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8.5MG
Packaging :
Approval Date : 2008-01-02
Application Number : 20356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NISOLDIN
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging : 60T, 300T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NISOLDIN
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging : 60T, 300T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2008-07-25
Application Number : 79051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2008-07-25
Application Number : 79051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2008-07-25
Application Number : 79051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 8.5MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 17MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25.5MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NISOLDIPINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 34MG
Packaging :
Approval Date : 2011-01-26
Application Number : 91001
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?